GlassScriptPhysician profile
Joseph C Klink
NPI 1073715744
$18,891.30
in general payments reported to CMS, 2019-2025
27 companies · $1,643 in 2025
The $1,643 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $324 · 2021: $430 · 2022: $481 · 2023: $8,584 · 2024: $7,135 · 2025: $1,643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,478 · Education: $5,500 · Food and Beverage: $4,299 · Gift: $84.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,478.06 |
| Education | $5,500.00 |
| Food and Beverage | $4,299.04 |
| Gift | $84.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,694.84 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Profound Medical Corp. | $1,254.30 | 2024 | Tulsa-Pro |
| Edap Technomed INC | $826.30 | 2023 | |
| Janssen Biotech, INC. | $476.37 | 2020-2025 | Erleada, Rybrevant, Carvykti |
| Astellas Pharma US INC | $230.81 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $205.58 | 2021-2023 | Lynparza |
| Endo Pharmaceuticals INC. | $159.09 | 2020-2022 | |
| Boston Scientific Corporation | $133.79 | 2020-2025 | Spaceoar Vue System - 10ml, Lithovue, Axonics |
| Abbvie INC. | $122.85 | 2020-2022 | |
| Coloplast Corp | $117.84 | 2019-2022 | |
| Pfizer INC. | $112.83 | 2021-2022 | |
| Medtronic, INC. | $93.08 | 2021-2023 | Interstim |
| Urogen Pharma, INC. | $76.27 | 2021-2025 | |
| Ethicon US, LLC | $72.72 | 2021-2022 | |
| Tolmar, INC. | $65.05 | 2023-2025 | Eligard |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $59.72 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.43 | 2021 | |
| Conmed Corporation | $28.96 | 2025 | Airseal |
| Dentsply Ih Ab | $22.57 | 2025 | Lofric |
| Progenics Pharmaceuticals, INC. | $19.82 | 2022 | |
| Blue Earth Diagnostics | $18.97 | 2021 | |
| Axonics, INC. | $16.33 | 2021 | |
| Urovant Sciences INC | $13.85 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 | |
| Allergan, INC. | $11.19 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Klink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.